DrugPatentWatch reveals NIH funding for patents
Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity […]
DrugPatentWatch reveals NIH funding for patents Read Post »
Insights
Pharma Patent Filing Strategies That Maximize Exclusivity: The Complete IP Playbook
For IP teams, portfolio managers, R&D leads, and institutional investors who need more than an overview. A pharmaceutical patent is
Pharma Patent Filing Strategies That Maximize Exclusivity: The Complete IP Playbook Read Post »
NPR and DrugPatentWatch – Can drug injector pens be swapped?
On NPR’s All Things Considered, Sydney Lupkin asked DrugPatentWatch if drug patents could be used to identify injector pens which
NPR and DrugPatentWatch – Can drug injector pens be swapped? Read Post »
The 505(b)(2) Playbook: Cut Dev Time, Lock In Exclusivity, and Outmaneuver Generics
1. Why the 505(b)(2) Pathway Exists and Who It Rewards The Hatch-Waxman Design Intent The Drug Price Competition and Patent
The 505(b)(2) Playbook: Cut Dev Time, Lock In Exclusivity, and Outmaneuver Generics Read Post »
DrugPatentWatch named “Best of the Web” by Genetic Engineering News
DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile
DrugPatentWatch named “Best of the Web” by Genetic Engineering News Read Post »
Sell the use, not the molecule
The innovation-exclusivity-reinvestment cycle The fundamental economic engine of the innovator pharmaceutical industry functions through a self-sustaining loop. This cycle begins
Sell the use, not the molecule Read Post »
Drug Patent Intelligence for Excipient Companies: The Complete Revenue Growth Playbook
1. What Excipients Actually Do (and Why the ‘Inactive’ Label Is Costing You Sales) The phrase ‘inactive ingredient’ is a
Drug Patent Intelligence for Excipient Companies: The Complete Revenue Growth Playbook Read Post »
DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform
We’re pleased to share that DrugPatentWatch has been recognized as the Best Biopharmaceuticals Commercial Business Intelligence Platform by Global Health
DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform Read Post »
Generic Drug Development: The Complete Regulatory, IP, and Market Strategy Playbook
1. Why Generic Drugs Are the Real Backbone of Pharma Economics Generic drugs saved the U.S. healthcare system $373 billion
Generic Drug Development: The Complete Regulatory, IP, and Market Strategy Playbook Read Post »
